Alabama Reps. Barry Moore (R-AL), Mo Brooks (R-AL), Mike Rogers (R-AL), and Gary Palmer (R-AL) are demanding answers from the Biden administration over its decision to effectively ration lifesaving coronavirus treatment– a move severely impacting southern states.
“We write today to convey Alabama’s concerns regarding the allocation of monoclonal antibody (mAb) treatments,” they wrote in an October 7 letter to Health and Human Services (HHS) Secretary Xavier Becerra.
Citing the department’s decision to ration the treatment, which the administration attributed to concerns of “equitable distribution,” the lawmakers said it has “caused Alabama to experience a significant drop in the amount of mAb dose availability, thus unnecessarily putting lives at risk.”
“HHS will determine the amount of product each state and territory receives on a weekly basis,” a spokesman for the U.S. Department of Health and Human Services (HHS) said at the time.
“Further, it appears many healthcare providers and clinics have struggled with anticipating shipments, resulting in patients being unable to receive mAb therapy,” the lawmakers continued.
“We ask HHS to clarify if the allocation formula will reduce the number of mAb doses allocated to states based on a state’s ability to properly report to HHS how many mAb’s were used,” they continued.
“Furthermore, we request an explanation of why there has been such a lack of clarity by HHS on when treatments will become available,” they continued.
“Lastly, we request HHS to state whether the mAb distribution formula change will impact Alabama’s allocation and, if so, HHS’s estimate of how much Alabama’s allocation will go up, or down, based on the new mAb allocation formula,” they added.
The letter follows several Republican lawmakers, including Sens. Rick Scott (R-FL), Marco Rubio (R-FL), Marsha Blackburn (R-TN), Roger Marshall (R-KS), Kevin Cramer (R-ND), Mike Braun (R-ID), and Tommy Tuberville (R-AL), introducing the TREAT Act, which would “nullify the Biden Administration’s recent policy requiring hospitals and other facilities to work through states to receive mAb supplies as well as cease the administration’s ability to throttle the state’s supply of this lifesaving treatment.”
COMMENTS
Please let us know if you're having issues with commenting.